AURO-SUNITINIB
As listed in the register: AURO-SUNITINIB
50 mg · capsule
- Prescription only
- Cancer treatments and immune-system medicines
- Active substance
- Sunitinib (Sunitinib Malate)
- Made by
- Auro Pharma Inc
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
Bulgaria5 matching products
European UnionNo exact match for this strength and form
Spain16 matching products
- SUNITINIB ACCORD 50 mg · cápsula dura
- SUNITINIB BLUEPHARMA INDUSTRIA 50 mg · cápsula dura
- SUNITINIB CIPLA 50 mg · cápsula dura
- SUNITINIB DR. REDDYS 50 mg · cápsula dura
- SUNITINIB EGIS 50 mg · cápsula dura
- SUNITINIB EUGIA 50 mg · cápsula dura
- SUNITINIB GLENMARK 50 mg · cápsula dura
- SUNITINIB KOANAA 50 mg · cápsula dura
Netherlands22 matching products
- Sunitinib Sandoz 50 mg 50 mg · capsule, hard2 makers
- Sunitinib Synthon 50 mg 50 mg · capsule, hard2 makers
- Egotux 50 mg harde capsules 50 mg · capsule, hard
- Klertis 50 mg harde capsules 50 mg · capsule, hard
- Lusmose 50 mg harde capsules 50 mg · capsule, hard
- Sunitinib Accord 50 mg 50 mg · capsule, hard
- Sunitinib betapharm 50 mg harde capsules 50 mg · capsule, hard
- Sunitinib CF 50 mg 50 mg · capsule, hard
SwitzerlandNo exact match for this strength and form
Details
| Made by | Auro Pharma Inc |
|---|---|
| Active substance | Sunitinib (Sunitinib Malate) |
| Used in | Cancer treatments and immune-system medicines |
| Strength | 50 mg |
| Form | capsule |
| Classification | L01EX01 · Cancer treatments and immune-system medicines |
| Route | oral |
| Dispensing (as stated by the register) | PRESCRIPTION |
| Status | Marketed |
| Marketed | Yes, according to the register |
| DIN | 02532220 |
| DPD drug code | 102129 |
Source: Drug Product Database · 2026-09-30 · not reviewed by a clinician
Contains information licensed under the Open Government Licence – Canada. Reuse terms: Open Government Licence – Canada.
Other strengths and forms
4 products are sold under this name. Grouped by form; a number on a strength means several companies make it.
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.